Navigation Links
Cempra Pharmaceuticals To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17th
Date:11/13/2009

CHAPEL HILL, N.C., Nov. 13 /PRNewswire/ -- Cempra Pharmaceuticals Inc. today announced that Prabhavathi Fernandes, president and chief executive officer, will present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 at 9:25 a.m. EST at The St. Regis Hotel in New York City. Dr. Fernandes will provide an overview of the company's two leading antibiotic clinical programs for the treatment of drug-resistant pathogens including MRSA.

About Cempra Pharmaceuticals

Founded in 2006, Cempra Pharmaceuticals is a privately-held, clinical-stage biotechnology company focused on developing antibacterials to address critical medical needs. Two lead products, both in late-stage clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra is well-funded and is committed to developing commercially viable products through consideration of pricing and reimbursement issues throughout its products' lifecycles. The company is also utilizing its proprietary chemistry technology to develop macrolides without antibacterial activity for non-antibiotic uses in motilin receptor activity, anti-inflammatory activity and GnRH receptor antagonism. Additional information about Cempra can be found at www.cempra.com.

    Media Contacts:
    Robert E. Flamm, Ph.D.
    Russo Partners, LLC
    (212) 845-4226
    Robert.flamm@russopartnersllc.com

    Tony Russo, Ph.D.
    Russo Partners, LLC
    (212) 845-4251
    Tony.russo@russopartnersllc.com

SOURCE Cempra Pharmaceuticals Inc.


'/>"/>
SOURCE Cempra Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
2. Presentations of Cempra Pharmaceuticals CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Alvarado Hospital unveiled its new facility ... & Joint Institute. The institute is entirely devoted ... surgery and joint replacement. The Spine & Joint ... experience-focused approach. For example, patients are encouraged to ... than patient gowns. "From the ...
(Date:7/29/2015)... LAKE FOREST, Calif. , July 29, ... ) ("Cryoport" or the "Company"), the leading ... the life sciences industry, serving markets including ... organizations, vaccine manufacturers, animal health, and reproductive ... completed the sale of common stock and warrants ...
(Date:7/29/2015)...  Ortho-Clinical Diagnostics, Inc. (OCD) today announced the presentation ... address a range of important tests for clinical labs ... The scientific posters will be delivered during the 2015 ... held July 26 - 30 in Atlanta, ... is emerging stronger than ever since becoming a stand-alone ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... DIEGO, Feb. 11, 2011 Conatus Pharmaceuticals Inc. today ... Preferred Stock private placement financing.  This financing was led ... and included participation by existing investors; Aberdare Ventures, Advent ... Roche Venture Fund.  Conatus will use the proceeds to ...
... LOS ANGELES, Feb. 11, 2011 Nationally-acclaimed researcher and ... speech at the 11th National Conference on Cancer Nursing ... potentially deadly infections they were supposed to prevent. ... needleless IV connector devices with silver coated or silver ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research 2
(Date:7/29/2015)... ... 30, 2015 , ... Macro Wealth Management (MWM) Presidents have increased ... Lifetime program by encouraging their clients to donate their MWM planning fees to the ... McClellan and Tim Streid, who see charitable giving as an important part of financial ...
(Date:7/29/2015)... City, NY (PRWEB) , ... July 30, 2015 ... ... honors Laura Ballard, M.S., MSTi, as a 2015-2016 inductee into ... this prestigious distinction for leadership in mental health counseling. With more than 700,000 ...
(Date:7/29/2015)... ... ... Avatar Solutions has received official approval from CMS to administer the Consumer ... for PQRS Survey collects information about patients’ experiences of care within the group ... they will receive a 2% penalty in 2017. At this point in time, practices ...
(Date:7/29/2015)... ... 29, 2015 , ... Conventional theories used by economists for the past 150 ... able to unlock mysteries about the behavior of microbial life on earth, according to ... University. , The findings, published July 29 in the open access journal PLOS ONE, ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... a vice president within Abt’s U.S. Health division. In her position, Ramkeesoon ... practices. , Prior to joining Abt, Ramkeesoon spent close to a decade at ...
Breaking Medicine News(10 mins):Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:NAPW Inducts Laura Ballard, Lead Clinician / Founder, Abundant Transformation / Evergreen Professional Counseling, Into its VIP Woman of the Year Circle 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2
... researchers have found that bipolar disorder is more costly ... or coronary artery disease. These findings are based on ... costs (the costs of seeing any specialist and all ... of this review are being presented today at the ...
... -- According to a new Mayo Clinic study, a ... of challenges facing depressed inpatients. Included are an increase ... a higher incidence rate of personality disorder. Additionally, these ... and an increase in psychiatric hospitalizations for psychiatric issues. ...
... 75th Birthday NEW YORK, May 21 Tonight ... be joined by prominent members of the entertainment, ... its co-founder Gloria Steinem,s 75th birthday and the ... to grassroots women activists and philanthropists who ignite ...
... LAUREL, N.J., May 21 The Commission for Case ... Annual Patricia McCollom $1,000 Scholarship. August 1 is the ... be used to help cover the cost of tuition, ... announce the scholarship winner in October, during Case Manager ...
... Meadowlands Helps Raise Awareness & Funds for Cystic FibrosisEAST RUTHERFORD, ... know that on average Cystic Fibrosis affects over 500 individuals ... While progress is being made to better understand what causes ... system, there,s no known cure -- only better treatments that ...
... Angeles, London, New Delhi, Singapore and Washington DC (May 21, ... such as MRI and CT scans, a literature review of ... Diagnostic Medical Sonography (JDMS) describes the use of ... the alternatives. , Since its first uses in the 1950s, ...
Cached Medicine News:Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 2Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 3Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 4Health News:CCMC Accepting Applications for Second Annual Patricia McCollom Scholarship Through Aug. 1 2Health News:State Fair Meadowlands Teams Up & Goes Trucking For Cystic Fibrosis Foundation 2Health News:State Fair Meadowlands Teams Up & Goes Trucking For Cystic Fibrosis Foundation 3
Arm Compression Garment...
Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
Sub Pectoral Bra...
Medicine Products: